Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:1210-1217
Published online before print February 7, 2008, doi: 10.1161/HYPERTENSIONAHA.107.106807
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
51/4/1210    most recent
HYPERTENSIONAHA.107.106807v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinna, C.
Right arrow Articles by Bolego, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinna, C.
Right arrow Articles by Bolego, C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
Related Collections
Right arrow Animal models of human disease
Right arrow Gene expression
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2008;51:1210.)
© 2008 American Heart Association, Inc.


Go Red Original Articles

Prolonged Ovarian Hormone Deprivation Impairs the Protective Vascular Actions of Estrogen Receptor {alpha}Agonists

Christian Pinna; Andrea Cignarella; Paola Sanvito; Valeria Pelosi; Chiara Bolego

From the Department of Pharmacological Sciences (C.P., A.C., P.S., V.P., C.B.), University of Milan, Milan, Italy; and the Department of Pharmacology and Anaesthesiology (A.C., P.S., V.P., C.B.), University of Padova, Padova, Italy.

Correspondence to Andrea Cignarella, Department of Pharmacology and Anaesthesiology, University of Padova, Largo Meneghetti 2, 35131 Padova, Italy. E-mail andrea.cignarella{at}unipd.it

The vascular consequences of estrogen treatment may be driven by its initiation timing. We tested the hypothesis that the duration of ovarian hormone deprivation before estrogen reintroduction affects the role of estrogen as mediator of endothelial function and vascular relaxation in nondiseased vessels. Rats were ovariectomized and implanted with 17β-estradiol (E2) or oil capsules 1, 4, and 8 months after surgery. After the longest hypoestrogenicity period, acetylcholine-mediated aortic relaxation was attenuated and insensitive to E2 administration despite endothelial integrity. Whereas no rapid vasorelaxant responses were elicited by an estrogen receptor (ER) β–selective agonist, responses to E2 and an ER{alpha} selective agonist waned postovariectomy at any given time and were restored by E2 treatment after 1 and 4 months but not 8 months postovariectomy. Accordingly, endothelial ER{alpha} mRNA and protein expression declined {approx}6-fold after prolonged hypoestrogenicity and was restored by estrogen replacement starting 1 month but not 8 months postovariectomy. Furthermore, the amount of active phosphorylated endothelial NO synthase rose significantly after E2 replacement after 1 and 4 months but not 8 months postovariectomy. The present findings document that the functional impairment of the ER{alpha}/endothelial NO synthase signaling network after an extended period of hypoestrogenicity was not restored by E2 administration, providing experimental support to early initiation of estrogen replacement with preferential ER{alpha} targeting to improve cardiovascular outcomes.


Key Words: endothelium • hormones • pharmacology • NO synthase • receptors




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Xing, S. Nozell, Y.-F. Chen, F. Hage, and S. Oparil
Estrogen and Mechanisms of Vascular Protection
Arterioscler. Thromb. Vasc. Biol., March 1, 2009; 29(3): 289 - 295.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. D. Roghair, J. L. Segar, K. A. Volk, M. W. Chapleau, L. M. Dallas, A. R. Sorenson, T. D. Scholz, and F. S. Lamb
Vascular nitric oxide and superoxide anion contribute to sex-specific programmed cardiovascular physiology in mice
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R651 - R662.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Cignarella, C. Bolego, V. Pelosi, C. Meda, A. Krust, C. Pinna, R. M. Gaion, E. Vegeto, and A. Maggi
Distinct Roles of Estrogen Receptor-{alpha} and {beta} in the Modulation of Vascular Inducible Nitric-Oxide Synthase in Diabetes
J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 174 - 182.
[Abstract] [Full Text] [PDF]